Health Condition 1: D561- Beta thalassemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: : Pediatric patients aged 1-18 years with transfusion dependent thalassemia with atleast 1 year since time of diagnosis who consent to be a part of the study.
Exclusion criteria
Exclusion criteria: 1. Known diabetic patients, those on insulin or oral hypoglycemic agents 2. Those with other significant systemic illnesses like cardiac failure, viral hepatitis, hepatocellular carcinoma and other neoplasias. 3. Those receiving hepatotoxic drugs 4. Those with syndromic illnesses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of glycemic abnormalitiesTimepoint: Single assessment at baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of beta cell functionTimepoint: Single assessment at baseline;Assessment of insulin sensitivity/resistanceTimepoint: Single assessment at baseline;Correlation of glycemic abnormalities and insulin resistance with serum ferritin levelsTimepoint: Single assessment at baseline;Comparison of fructosamine levels with HbA1c for detection of glucose abnormalitiesTimepoint: Single assessment at baseline | — |
Countries
India
Contacts
KAHERs JAWAHARLAL NEHRU MEDICAL COLLEGE